NEXTRANS Announces Third Annual High School Essay Competition
August 30, 2011
The NEXTRANS Center at Purdue University is sponsoring its third high school essay competition for students residing in Indiana. The contest’s goal is to encourage students to consider how integral transportation is to the future of Indiana and our nation, and potentially interest them in transportation-related careers and/or higher education in the field. NEXTRANS is seeking articulate and well-researched essays of up to 1500 words on the following topic: What factor(s) do you think will most affect the future of transportation in Indiana and across the nation?
Please submit a clear, well-organized and well-researched essay of up to 1500 words adhering to the provided topic.
• Entries must be typed in 12-point font with one-inch margins, printed on one side.
• Please staple entries, include page numbers and a title.
• The student’s name should not appear on the essay itself.
On a separate cover sheet, please provide the following information:
• Contact information (address, phone and email)
• Current grade in school
• Name and location of high school
Please mail these materials on or before December 9, 2011 to:
NEXTRANS 2011 High School
3000 Kent Avenue
West Lafayette, IN 47906
All public, private and homeschooled high school students (grades 9-12) currently residing in Indiana are eligible to enter. Additional questions may be directed to Andrea McIntyre at 765-496-9734 or via email at firstname.lastname@example.org.
September 26, 2014
Officials of a pharmaceutical startup based on a Purdue University innovation say their company is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered medicine.Read Full Story
September 25, 2014
Purdue researchers have discovered the structure of the enzyme that makes cellulose, a finding that could lead to easier ways of breaking down plant materials to make biofuels and other products and materials.Read Full Story
September 17, 2014
A Purdue startup is commercializing a technology that could reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.Read Full Story